Thư viện tập trung - Thư viện điện tử

Sách, tuyển tập

Tài liệu điện tử

Pharmaceutical regulation in 15 European countries: review / World Health Organization. Regional Office for Europe;European Observatory on Health Systems and Policies;Panteli, Dimitra;Arickx, Francis;Cleemput, Irina;Dedet, Guillaume;Eckhardt, Helene;Fogarty, Emer;Gerkens, Sophie;Henschke, Cornelia;Hislop, Jennifer;Jommi, Claudio;Kaitelidou, Daphne;Kawalec, Pawel;Keskimäki, Ilmo;Kroneman, Madelon;Lopez Bastida, Julio;Barros, Pedro Pita;Ramsberg, Joakim;Schneider, Peter;Spillane, Susan;Vogler, Sabine;Vuorenkoski, Lauri;Wallach Kildemoes, Helle;Wouters, Olivier;Busse, Reinhard

Tác giả : World Health Organization. Regional Office for Europe;European Observatory on Health Systems and Policies;Panteli, Dimitra;Arickx, Francis;Cleemput, Irina;Dedet, Guillaume;Eckhardt, Helene;Fogarty, Emer;Gerkens, Sophie;Henschke, Cornelia;Hislop, Jennifer;Jommi, Claudio;Kaitelidou, Daphne;Kawalec, Pawel;Keskimäki, Ilmo;Kroneman, Madelon;Lopez Bastida, Julio;Barros, Pedro Pita;Ramsberg, Joakim;Schneider, Peter;Spillane, Susan;Vogler, Sabine;Vuorenkoski, Lauri;Wallach Kildemoes, Helle;Wouters, Olivier;Busse, Reinhard

Nhà xuất bản : World Health Organization. Regional Office for Europe

Năm xuất bản : 2016

Tùng thư : Health Systems in Transition. vol. 18 (5)

Chủ đề : 1. Delivery of Health Care -- organization and administration. 2. Evaluation Studies. 3. Health Care Reform. 4. Health Systems Plans. 5. Healthcare Financing. 6. Pharmaceutical Services. 7. Publications.

Chia sẻ

Thông tin chi tiết

Tóm tắt :

122 p. In the context of pharmaceutical care, policy-makers repeatedly facethe challenge of balancing patient access to effective medicines withaffordability and rising costs. With the aim of guiding the health policydiscourse towards questions that are important to actual and potential patients,this study investigates a broad range of regulatory measures, spanningmarketing authorization to generic substitution and resulting price levels in asample of 16 European health systems (Austria, Belgium, Denmark, England,Finland, France, Germany, Greece, Ireland, Italy, the Netherlands, Poland,Portugal, Scotland, Spain and Sweden).All countries employ a mix of regulatory mechanisms to containpharmaceutical expenditure and ensure quality and efficiency in pharmaceuticalcare, albeit with varying configurations and rigour. This variation alsoinfluences the extent of publicly financed pharmaceutical costs. Overall,observed differences in pharmaceutical expenditure should be interpreted inconjunction with the differing volume and composition of consumption andprice levels, as well as dispensation practices and their impact on measurementof pharmaceutical costs.No definitive evidence has yet been produced on the effects of differentcost-containment measures on patient outcomes. Depending on the foremostpolicy concerns in each country, different levers will have to be used to enablethe delivery of appropriate care at affordable prices.

Chia sẻ

Hiển thị MARC

Thông tin dữ liệu nguồn

Thư viện	Ký hiệu xếp giá	Dữ liệu nguồn
Tổ chức y tế thế giới		https://iris.who.int/handle/10665/330240

Ldr		00025nam a2200024 a 4500
001		CLN251769013
022	__	$a1817-6119
041	__	$aen
100	__	$aWorld Health Organization. Regional Office for Europe
245	__	$aPharmaceutical regulation in 15 European countries: review /$cWorld Health Organization. Regional Office for Europe;European Observatory on Health Systems and Policies;Panteli, Dimitra;Arickx, Francis;Cleemput, Irina;Dedet, Guillaume;Eckhardt, Helene;Fogarty, Emer;Gerkens, Sophie;Henschke, Cornelia;Hislop, Jennifer;Jommi, Claudio;Kaitelidou, Daphne;Kawalec, Pawel;Keskimäki, Ilmo;Kroneman, Madelon;Lopez Bastida, Julio;Barros, Pedro Pita;Ramsberg, Joakim;Schneider, Peter;Spillane, Susan;Vogler, Sabine;Vuorenkoski, Lauri;Wallach Kildemoes, Helle;Wouters, Olivier;Busse, Reinhard
260	__	$bWorld Health Organization. Regional Office for Europe ,$c2016
490	__	$aHealth Systems in Transition. vol. 18 (5)
520	__	$a122 p.
520	__	$aIn the context of pharmaceutical care, policy-makers repeatedly facethe challenge of balancing patient access to effective medicines withaffordability and rising costs. With the aim of guiding the health policydiscourse towards questions that are important to actual and potential patients,this study investigates a broad range of regulatory measures, spanningmarketing authorization to generic substitution and resulting price levels in asample of 16 European health systems (Austria, Belgium, Denmark, England,Finland, France, Germany, Greece, Ireland, Italy, the Netherlands, Poland,Portugal, Scotland, Spain and Sweden).All countries employ a mix of regulatory mechanisms to containpharmaceutical expenditure and ensure quality and efficiency in pharmaceuticalcare, albeit with varying configurations and rigour. This variation alsoinfluences the extent of publicly financed pharmaceutical costs. Overall,observed differences in pharmaceutical expenditure should be interpreted inconjunction with the differing volume and composition of consumption andprice levels, as well as dispensation practices and their impact on measurementof pharmaceutical costs.No definitive evidence has yet been produced on the effects of differentcost-containment measures on patient outcomes. Depending on the foremostpolicy concerns in each country, different levers will have to be used to enablethe delivery of appropriate care at affordable prices.
650	_2	$aDelivery of Health Care $xorganization and administration
650	_2	$aEvaluation Studies
650	_2	$aHealthcare Financing
650	_2	$aHealth Care Reform
650	_2	$aHealth Systems Plans
650	_2	$aPharmaceutical Services
655	__	$aPublications
700	__	$aEuropean Observatory on Health Systems and Policies
700	__	$aPanteli, Dimitra
700	__	$aArickx, Francis
700	__	$aCleemput, Irina
700	__	$aDedet, Guillaume
700	__	$aEckhardt, Helene
700	__	$aFogarty, Emer
700	__	$aGerkens, Sophie
700	__	$aHenschke, Cornelia
700	__	$aHislop, Jennifer
700	__	$aJommi, Claudio
700	__	$aKaitelidou, Daphne
700	__	$aKawalec, Pawel
700	__	$aKeskimäki, Ilmo
700	__	$aKroneman, Madelon
700	__	$aLopez Bastida, Julio
700	__	$aBarros, Pedro Pita
700	__	$aRamsberg, Joakim
700	__	$aSchneider, Peter
700	__	$aSpillane, Susan
700	__	$aVogler, Sabine
700	__	$aVuorenkoski, Lauri
700	__	$aWallach Kildemoes, Helle
700	__	$aWouters, Olivier
700	__	$aBusse, Reinhard
856	__	$uhttps://iris.who.int/handle/10665/330240
900		1
907		https://iris.who.int/bitstream/handle/10665/330240/HiT-18-5-2016-eng.pdf.jpg?sequence=9&isAllowed=y
925		G
926		0
927		SH

Thông tin dữ liệu nguồn

Tài liệu cùng tác giả

Public health aspects of alcohol and drug dependence: report on a WHO conference, Dubrovnik, 21–25 August 1978 / World Health Organization. Regional Office for Europe

Environmental health impact assessment: report on a WHO seminar, Argostoli, Kefalonia, Greece, 2–6 October 1978 / World Health Organization. Regional Office for Europe

Writing about suicide in a responsible way: training course for media professionals and students / World Health Organization. Regional Office for Europe

Manpower development in toxicology: report on a WHO consultation, Copenhagen, 11–15 December 1978 / World Health Organization. Regional Office for Europe

Setting the foundation for quality management in home- and community-based long-term care / World Health Organization. Regional Office for Europe

Lời ngỏ

Mục đích và phương châm hoạt động

Bản quyền